GREENWICH LIFESCIENCES, INC. Amortization
GREENWICH LIFESCIENCES, INC. (GLSI) reported Amortization of $1.78 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-08-11
- GREENWICH LIFESCIENCES, INC. amortization for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- GREENWICH LIFESCIENCES, INC. amortization for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- GREENWICH LIFESCIENCES, INC. amortization for the quarter ending 2025-06-30 was $876.00, a 2.99% decline year-over-year.
- GREENWICH LIFESCIENCES, INC. amortization for the quarter ending 2025-03-31 was $903.00, a 0.00% change year-over-year.
- GREENWICH LIFESCIENCES, INC. amortization for fiscal 2025 was $1.78K, a 50.75% decline from fiscal 2024.
- GREENWICH LIFESCIENCES, INC. amortization for fiscal 2024 was $3.61K, a 0.00% change from fiscal 2023.
- GREENWICH LIFESCIENCES, INC. amortization for fiscal 2023 was $3.61K, a 0.00% change from fiscal 2022.
- GREENWICH LIFESCIENCES, INC. amortization for fiscal 2022 was $3.61K, a 0.00% change from fiscal 2021.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $0.00 derived: sum of 2 quarters · filed 2026-06-01 | $876.00 derived: sum of 3 quarters · filed 2026-08-11 | $1.78K 10-K · filed 2026-06-01 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $876.00 derived: sum of 2 quarters · filed 2026-08-11 | $1.78K 10-Q · filed 2025-11-14 | $2.68K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $876.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.78K 10-Q · filed 2026-08-11 | $2.68K derived: sum of 3 quarters · filed 2026-08-11 | $3.58K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $903.00 10-Q · filed 2026-06-04 | $1.81K derived: sum of 2 quarters · filed 2026-06-04 | $2.71K derived: sum of 3 quarters · filed 2026-06-04 | $3.61K derived: sum of 4 quarters · filed 2026-06-04 |
| 2024-12-31 | $903.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $1.81K derived: sum of 2 quarters · filed 2026-06-01 | $2.71K derived: sum of 3 quarters · filed 2026-06-01 | $3.61K 10-K · filed 2026-06-01 |
| 2024-09-30 | $903.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.81K derived: sum of 2 quarters · filed 2025-11-14 | $2.71K 10-Q · filed 2025-11-14 | $3.61K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $903.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.81K 10-Q · filed 2025-08-14 | $2.71K derived: sum of 3 quarters · filed 2025-08-14 | $3.61K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $903.00 10-Q · filed 2025-05-20 | $1.81K derived: sum of 2 quarters · filed 2025-05-20 | $2.71K derived: sum of 3 quarters · filed 2025-05-20 | $3.61K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $903.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.81K derived: sum of 2 quarters · filed 2025-04-15 | $2.71K derived: sum of 3 quarters · filed 2025-04-15 | $3.61K 10-K · filed 2025-04-15 |
| 2023-09-30 | $903.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.81K derived: sum of 2 quarters · filed 2024-11-14 | $2.71K 10-Q · filed 2024-11-14 | $3.61K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $903.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.81K 10-Q · filed 2024-08-14 | $2.71K derived: sum of 3 quarters · filed 2024-08-14 | $3.61K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $903.00 10-Q · filed 2024-05-20 | $1.81K derived: sum of 2 quarters · filed 2024-05-20 | $2.71K derived: sum of 3 quarters · filed 2024-05-20 | $3.61K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $903.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $1.81K derived: sum of 2 quarters · filed 2024-04-15 | $2.71K derived: sum of 3 quarters · filed 2024-04-15 | $3.61K 10-K · filed 2024-04-15 |
| 2022-09-30 | $903.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-19 | $1.81K derived: sum of 2 quarters · filed 2023-10-19 | $2.71K 10-Q · filed 2023-10-19 | $3.61K derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-06-30 | $903.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $1.81K 10-Q · filed 2023-08-21 | $2.71K derived: sum of 3 quarters · filed 2023-08-21 | $3.61K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | $903.00 10-Q · filed 2023-05-22 | $1.81K derived: sum of 2 quarters · filed 2023-05-22 | $2.71K derived: sum of 3 quarters · filed 2023-05-22 | $3.61K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $903.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.81K derived: sum of 2 quarters · filed 2023-03-31 | $2.71K derived: sum of 3 quarters · filed 2023-03-31 | $3.61K 10-K · filed 2023-03-31 |
| 2021-09-30 | $903.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.81K derived: sum of 2 quarters · filed 2022-11-14 | $2.71K 10-Q · filed 2022-11-14 | $3.61K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $903.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.81K 10-Q · filed 2022-08-15 | $2.71K derived: sum of 3 quarters · filed 2022-08-15 | $3.61K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $903.00 10-Q · filed 2022-05-20 | $1.81K derived: sum of 2 quarters · filed 2022-05-20 | $2.71K derived: sum of 3 quarters · filed 2022-05-20 | $3.61K derived: sum of 4 quarters · filed 2022-05-20 |
| 2020-12-31 | $903.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.81K derived: sum of 2 quarters · filed 2022-03-21 | $2.71K derived: sum of 3 quarters · filed 2022-03-21 | $3.61K 10-K · filed 2022-03-21 |
| 2020-09-30 | $903.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.80K derived: sum of 2 quarters · filed 2021-11-15 | $2.71K 10-Q · filed 2021-11-15 | $3.61K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $901.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.80K 10-Q · filed 2021-08-13 | $2.71K derived: sum of 3 quarters · filed 2021-08-13 | |
| 2020-03-31 | $902.00 10-Q · filed 2021-05-20 | $1.80K derived: sum of 2 quarters · filed 2021-05-20 | ||
| 2019-12-31 | $902.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $3.61K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $2.71K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |